QXO Q3 2026: Adjusted EPS Positive, But Operating Proof Still Missing

What happened

QXO reported a Q3 2026 basic loss per share of $(0.17) but adjusted diluted EPS of $0.13, reflecting the first full quarter including both Kodiak and TopBuild. The gap between GAAP and adjusted figures signals continued heavy add-backs for acquisition-related costs and purchase accounting, obscuring underlying profitability. No cash flow, gross margin, or EBITDA figures were provided in the press release, leaving the key integration proof points identified in prior analysis unaddressed. Adjusted EPS alone does not demonstrate the required sequential margin expansion or operating cash flow inflection above $150 million per quarter. Consequently, the quarter offers limited validation of the scale and synergy thesis, and management's adjusted metric should be treated with skepticism.

Implication

Investors should demand more than adjusted EPS: upcoming filings must confirm gross margin expansion, EBITDA growth, and operating cash flow above $150 million per quarter. The Q3 GAAP loss of $(0.17) per share shows that one-time charges and purchase accounting still mask underlying economics, so adjusted numbers should be viewed critically. Until cash conversion improves and leverage starts declining, the stock likely remains rangebound between $11 and $17. A more constructive stance would require sequential improvement in reported margins and clear operating cash flow inflection. Conversely, if Q4 shows flat margins or cash flow stagnation, the bear case strengthens and the stock could retest the $11 entry level.

Thesis delta

The prior thesis called for a WAIT, expecting Q3/Q4 to show gross margin expansion, EBITDA growth, and operating cash flow above $150 million. Q3's positive adjusted EPS is encouraging but lacks accompanying cash flow or margin data, so the core uncertainty remains unresolved. The thesis does not change, but the burden of proof now shifts to the Q4 report and detailed 10-Q disclosures.